NASDAQ:ARTV | Income Statement | Artiva Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$21.93M$26.89M-$26.89M$1.89M-$25.01M-$0.63-$0.6339,413,23639,413,236
2026-03-31$19.31M$24.43M-$24.43M$914,000.00-$23.52M-$0.95-$0.9524,678,42024,678,420
2025-12-31$16.99M$21.93M-$21.93M$1.16M-$20.77M-$0.84-$0.8442,70442,704
2025-09-30$17.63M$22.9M-$22.9M$1.37M-$21.53M-$0.88-$0.8824,481,72224,481,722
2025-06-30$17.86M$22.81M-$22.81M$1.56M-$21.25M-$0.87-$0.8724,378,82324,378,823
2025-03-31$17.05M$22.17M-$22.17M$1.86M-$20.31M-$0.83-$0.8324,341,97824,341,978
2024-12-31$0.00$13.32M$18.27M-$18.27M$2.17M-$16.1M$1.35$1.354,375,5804,375,580
2024-09-30$13.52M$18.34M-$18.34M$863,000.00-$17.47M-$0.92-$0.9218,896,82918,896,829
2024-06-30$12.33M$16.19M-$16.19M-$1.65M-$17.84M-$22.00-$22.00811,210811,210
2024-03-31$251,000.00$11.16M$14.74M-$14.49M$529,000.00-$13.96M-$17.24-$17.24809,758809,758
2023-12-31$1.78M$11.15M$14.32M-$11.97M$44,000.00-$12M-$14.89-$14.892,2062,206
2023-09-30$26.66M$13.07M$15.85M$10.81M$468,000.00$11.28M$13.98$1.62806,7146,967,099
2023-06-30$3.5M$11.26M$15.32M-$11.82M$540,000.00-$11.28M-$14.09-$14.09800,889800,889
2023-03-31-$16.72M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$69.54M$89.81M-$89.81M$5.95M$0.00-$83.87M-$3.43-$3.4324,444,05724,444,057
2024-12-31$251,000.00$50.33M$67.53M-$67.28M$1.91M-$65.37M$0.00-$65.37M-$5.81-$5.8111,258,85111,258,851
2023-12-31$32.92M$50.25M$64.16M-$30.67M$2.02M-$28.65M$72,000.00-$28.72M-$35.78-$35.78802,747802,747